The US Food and Drug Administration has sent a record-low number of quality-related warning letters to medical device makers for the third year in a row.
That’s according to calendar year 2019 agency data shared with Medtech Insight. It shows that 21 of the enforcement missives – 17 domestic, four foreign – were issued to firms...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?